Data / Form D filings / Avenacy Inc.
Avenacy Inc.: Form D filing
Avenacy Inc., a pharmaceuticals company in Schaumburg, IL, filed a Form D with the SEC in 2024. The latest, on November 26, 2024, reports $26 million sold of a $34 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10 N MARTINGALE RD, SUITE 225, Schaumburg, IL, 60173
- Phone
- (877) 283-6229
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2046254
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | New notice | $34,030,368 | $26,030,368 | $8,000,000 | 2 | Nov 15, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick Soon-Shiong | Director | |
| Jeffrey Yordon | Executive Officer, Director | |
| Joe Reed Mase | Executive Officer | |
| Douglas Reed Maughan | Director | |
| Kam Phulwani | Executive Officer, Director |
Every Form D from the week of Nov 25, 2024 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Avenacy Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.